Catalyst Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 35 U.S.-traded ETFs. CPRX has around 7.0M shares in the U.S. ETF market. The largest ETF holder of CPRX is the iShares Russell 2000 ETF (IWM), with approximately 2.21M shares. Investors may also find of interest that the ETF with the largest allocation to CPRX stock is Invesco DWA Healthcare Momentum ETF (PTH), with a portfolio weight of 0.66%. On average, U.S. ETFs allocate 0.08% of CPRX to their portfolios.
Additionally, CPRX is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CPRX as a holding is the Invesco DWA NASDAQ Momentum ETF (DWAQ), with a return of 17.61%.